Clarivate PLC (NYSE:CLVT) Receives $3.22 Consensus Price Target from Analysts

Clarivate PLC (NYSE:CLVT) has been given a consensus rating of “Reduce” by the eight analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $3.2167.

Several equities research analysts have issued reports on the company. Royal Bank Of Canada lowered their price target on Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a report on Wednesday, February 25th. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Citigroup decreased their price target on Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research note on Wednesday, March 4th. Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Barclays dropped their price objective on Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a report on Wednesday, February 25th.

Institutional Investors Weigh In On Clarivate

A number of institutional investors have recently made changes to their positions in CLVT. Personal CFO Solutions LLC bought a new stake in shares of Clarivate in the 1st quarter valued at about $30,000. FreeGulliver LLC bought a new stake in shares of Clarivate in the 1st quarter valued at about $30,000. Principal Financial Group Inc. bought a new stake in shares of Clarivate in the 1st quarter valued at about $32,000. M&T Bank Corp bought a new stake in shares of Clarivate in the 4th quarter valued at about $34,000. Finally, Parallel Advisors LLC grew its position in shares of Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after buying an additional 6,687 shares during the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Stock Down 0.2%

Shares of CLVT stock opened at $2.21 on Wednesday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm has a market cap of $1.41 billion, a PE ratio of -10.50 and a beta of 1.37. The stock has a 50 day moving average of $2.52 and a 200-day moving average of $2.74. Clarivate has a 12 month low of $1.66 and a 12 month high of $4.77.

Clarivate (NYSE:CLVT) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04. The company had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business’s revenue was down 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.14 earnings per share. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, equities analysts predict that Clarivate will post 0.65 EPS for the current year.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.